Abstract
The aim of this study was to assess the practicality of treating patients with various stages of breast cancer by means of regional (intra-arterial) chemotherapy. Three groups of patients received a median of four (range 2-4) cycles of combination chemotherapy: group I operable primary (n = 10); group II, locally advanced disease (n = 20); group III, recurrent locoregional disease (n = 22). The response rates (complete response, partial response and mixed response) in these groups of patients were 100% in groups I and II and 86% in group III. Morbidity included drug streaming and dysaesthesia in the hand. Patients in groups I and II had their tumours downstaged, allowing surgery to be performed. Local control was also achieved in group III when other treatment modalities had failed.
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / surgery
-
Combined Modality Therapy
-
Doxorubicin / administration & dosage
-
Doxorubicin / adverse effects
-
Drug Administration Schedule
-
Feasibility Studies
-
Female
-
Fluorouracil / administration & dosage
-
Fluorouracil / adverse effects
-
Humans
-
Infusions, Intra-Arterial
-
Leucovorin / administration & dosage
-
Leucovorin / adverse effects
-
Methotrexate / administration & dosage
-
Methotrexate / adverse effects
-
Middle Aged
-
Mitomycin / administration & dosage*
-
Mitomycin / adverse effects
-
Mitoxantrone / administration & dosage
-
Mitoxantrone / adverse effects
-
Neoplasm Staging
Substances
-
Mitomycin
-
Doxorubicin
-
Mitoxantrone
-
Leucovorin
-
Fluorouracil
-
Methotrexate
Supplementary concepts
-
ALF protocol
-
MALF protocol
-
MMM protocol 2